Cardiac Magnetic Resonance Imaging (CMR)
Cardiac Magnetic Resonance Imaging (CMR) is an intervention with 10 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Highest Phase Reached
UnknownTrial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
2
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Using Cardiac MRI to Predict Outcomes in Patients With STEMI
Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR)
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer
Novel Cardiac Magnetic Resonance Imaging to Define a Unique Restrictive Cardiomyopathy in Sickle Cell Disease
Clinical Trials (10)
Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)
Using Cardiac MRI to Predict Outcomes in Patients With STEMI
Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance (R-COVID-CMR)
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer
Novel Cardiac Magnetic Resonance Imaging to Define a Unique Restrictive Cardiomyopathy in Sickle Cell Disease
Cardiac MRI for Metal on Metal Hip Resurfacing
CMR in Type 2 Diabetes Mellitus Patients
A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study)
Non-Invasive Determination of Cardiac Output by Electrical Velocimetry
Non-Invasive Determination of Cardiac Output by Inertgas Rebreathing Method
All 10 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 10